In this study, the researchers want to focus on the prevalence of anti-HEV antibodies by a new generation test, direct detection of HEV RNA, and its genotypic analysis in a group of human tissue and cell donors.
At the Department of Laboratory Medicine of the Faculty of Medicine of the Faculty of Medicine of the National University of Health Sciences, human tissue and cells from donors will be examined for the assessment of health eligibility and donor selection according to Decree No. 422/2008 Coll. According to the current legislation, the determination of IgG and IgM antibodies against HEV or the HEV RNA method is not part of the standard examination of human tissue and cell donors for the assessment of their health eligibility.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Enrollment
300
Diagnostic test used to determine antibodies in blood and serum.
University Hospital Ostrava
Ostrava, Moravian-Silesian Region, Czechia
RECRUITINGPrevalence of Hepatitis E in the study groups
The prevalence of Hepatitis E will be observed in both study groups, measured as the number of positive samples from the total number of samples.
Time frame: 2 years
Presence of Hepatitis E (HEV) RNA in the study groups
The presence of HEV RNA will be observed in both study groups, measured as the number of positive samples from the total number of samples.
Time frame: 2 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.